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Processes of consent in research for adults
with impaired mental capacity nearing the
end of life: systematic review and
transparent expert consultation
(MORECare_Capacity statement)
C. J. Evans1,2* , E. Yorganci1, P. Lewis3, J. Koffman1, K. Stone1, I. Tunnard1, B. Wee4, W. Bernal5, M. Hotopf6,
I. J. Higginson1 and on behalf of MORECare_Capacity
Abstract
Background: Involving adults lacking capacity (ALC) in research on end of life care (EoLC) or serious illness is
important, but often omitted. We aimed to develop evidence-based guidance on how best to include individuals
with impaired capacity nearing the end of life in research, by identifying the challenges and solutions for processes
of consent across the capacity spectrum.
Methods: Methods Of Researching End of Life Care_Capacity (MORECare_C) furthers the MORECare statement on
research evaluating EoLC. We used simultaneous methods of systematic review and transparent expert consultation
(TEC). The systematic review involved four electronic databases searches. The eligibility criteria identified studies
involving adults with serious illness and impaired capacity, and methods for recruitment in research, implementing
the research methods, and exploring public attitudes. The TEC involved stakeholder consultation to discuss and
generate recommendations, and a Delphi survey and an expert ‘think-tank’ to explore consensus. We narratively
synthesised the literature mapping processes of consent with recruitment outcomes, solutions, and challenges. We
explored recommendation consensus using descriptive statistics. Synthesis of all the findings informed the
guidance statement.
(Continued on next page)
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Results: Of the 5539 articles identified, 91 met eligibility. The studies encompassed people with dementia (27%)
and in palliative care (18%). Seventy-five percent used observational designs. Studies on research methods (37
studies) focused on processes of proxy decision-making, advance consent, and deferred consent. Studies
implementing research methods (30 studies) demonstrated the role of family members as both proxy decision-
makers and supporting decision-making for the person with impaired capacity. The TEC involved 43 participants
who generated 29 recommendations, with consensus that indicated. Key areas were the timeliness of the consent
process and maximising an individual’s decisional capacity. The think-tank (n = 19) refined equivocal
recommendations including supporting proxy decision-makers, training practitioners, and incorporating legislative
frameworks.
Conclusions: The MORECare_C statement details 20 solutions to recruit ALC nearing the EoL in research. The
statement provides much needed guidance to enrol individuals with serious illness in research. Key is involving
family members early and designing study procedures to accommodate variable and changeable levels of capacity.
The statement demonstrates the ethical imperative and processes of recruiting adults across the capacity spectrum
in varying populations and settings.
Keywords: Palliative care, Terminal care, Decision-making, Consent, Methods, Ethics, Systematic review, Consensus
Background
There is an urgent need for evidence on best practice in
palliative care. The projected increases in global serious
health-related suffering demand immediate action. By
2060, an estimated 48 million people will die globally
with serious related-suffering, representing an 87% in-
crease from the 26 million in 2016 [1]. Failing to re-
spond will see 80% of people globally with little or no
access to palliative care services and treatment [2]. A
major barrier in research on palliative care is ethical
concerns about the perceived vulnerability of adults with
serious illness and including them in research, particu-
larly if the person also has impaired mental capacity [3].
Exclusion of adults with impaired capacity to consent
for themselves impedes evidence-based care and treat-
ment that is applicable across the illness trajectory and
end of life (EoL) [4]. New interventions require robust
evaluation to examine benefit and potential of harm for
the population intending to benefit [5, 6]. Studies, espe-
cially clinical trials in palliative care, are often compro-
mised by insufficient sample size to detect change [7–
13], and impaired understanding of legislation governing
research involving adults with impaired capacity [14].
The ethical challenges of recruiting individuals with im-
paired capacity are examined across fields involving
adults with serious illness including palliative care [15],
dementia [16–18], mental health [19], and intensive care
[20]. Systematic reviews have considered consent pro-
cesses in specific conditions (e.g. dementia [21], schizo-
phrenia [22]) and aspects of involving adults lacking
capacity in research (e.g. capacity assessment [22], en-
hancing informed consent with older people [23, 24],
and strategies for designing research studies [25] and in-
creasing the recruitment rate in palliative care [26]). But,
in palliative care, intervention studies are few and often
exclude adults lacking capacity, for example in the dying
phase [27]. There is literature from both within and out-
side the field of palliative care that could inform much
needed guidance on best practice on processes of con-
sent across the capacity spectrum in serious illness. This
study aimed to determine how best to include individ-
uals with impaired capacity in research on EoLC by
identifying challenges for and solutions to processes of
consent across the capacity spectrum. This paper reports
the integrated results from a systematic review and
transparent expert consultation to form the MORECare_
Capacity statement on processes of consent in research
on EoLC. This furthers the Methods Of Researching
End of Life Care (MORECare) statement on evaluating
complex circumstances in EoLC [28] by giving detailed
consideration on processes of consent for adults with
serious illness across the capacity trajectory. The MORE-
Care statement omitted this area, focusing on outcome
measurement, response shift and attrition, integrating
mixed methods and economic evaluation.
In this paper, ‘capacity’ refers to mental capacity to
make an informed decision regarding research participa-
tion. ‘The spectrum of capacity’ of individuals ranges
from potentially impaired, and anticipated to have im-
paired capacity, to lacking capacity. The legislation gov-
erning involvement of adults lacking capacity in research
and terminology is jurisdiction specific. In this paper,
the term ‘consultee’ (someone who has capacity) is used
to encompass the different terms used in respective ju-
risdictions including but not limited to proxy-decision
maker, personal consultee and nominated consultee. A
distinction is made between a personal consultee (e.g.
family member) and a nominated consultee (e.g. health
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professional) [29]. ‘The process of consent’ refers to the
steps taken to ensure that an eligible research participant
is sufficiently informed about the purposes, content, af-
filiations of the study, and their right to withdraw from
the study at any point, enabling them or their consultee
to decide freely about research participation [30].
Methods
Study design
We used a parallel iterative research design detailed in
Fig. 1. We used methods of systematic literature review to
identify and map the challenges and solutions for pro-
cesses of consent for adults with impaired capacity, and
the MORECare transparent expert consultation (TEC) to
debate key areas [28] of uncertainty/contention. The TEC
involved expert stakeholder consultations using consensus
methods of modified nominal group technique to generate
recommendations [31], and then presenting the recom-
mendations in an online Delphi survey to explore levels of
agreement [32]. We held a final expert think-tank to ex-
plore areas of contention/uncertainty and synthesise the
findings to develop the statement. King’s College London
Research Ethics Committee approved the TEC compo-
nent (ref no. BDM/10/11-90).
Systematic review
Design
We used systematic review method of narrative synthesis
to systematically identify, appraise, and synthesise
quantitative and qualitative literature [33]. Methods of
analysis and inclusion criteria were pre-defined in the
study protocol. Reporting followed the PRISMA guid-
ance [34] (see Additional file 1: Table S1).
Eligibility criteria
Population Adults (≥ 18 years old) with impaired cap-
acity encompassing declining capacity (e.g. mild to mod-
erate dementia), fluctuating capacity (e.g. delirium), and
lack of capacity (e.g. dying, advanced dementia) are
included.
Context The scoping of the literature identified areas
recruiting adults lacking capacity with serious illness in
research. We included studies from palliative care, men-
tal health (delirium, dementia, learning disabilities), or
emergency medicine/critical care.
Interest Studies discussing consent in its various forms
(e.g. informed, advanced, proxy) and impaired mental
capacity are included. We did not restrict by health or
behaviour outcome. We focused on research studies in-
vestigating either of the following: (i) methods for in-
volving adults with impaired capacity in research, (ii)
implementing research methods to enable recruitment,
or (iii) exploring public attitudes and ethical issues on
involvement in research.
Fig. 1 Overview of the study design
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Design Randomised controlled trials (RCTs) and quasi-
experimental, mixed method, or observational qualitative
or quantitative designs are included. We included pub-
lished study protocols that reported the methods of con-
sent to enhance understanding for the main study. We
excluded systematic reviews but used relevant systematic
reviews for reference chaining by screening the cited
publications for eligibility. We excluded opinion pieces
and commentaries and non-English language papers.
Studies concerning treatment/clinical decision-making
or bioethics were out of scope.
Search strategy
We developed search strategies for each of the popula-
tion groups—palliative care, mental health (including de-
mentia), and emergency medicine/critical care. MeSH
terms for the palliative care group included ‘Terminally
ill’ or ‘Palliative Care’ AND ‘Decision making’ or ‘Mental
Competency’ AND ‘Informed consent’ or ‘Third-party
consent’. Key search terms were used as free-text, and
with use of truncation symbol to retrieve variations in
the terminology. Search terms were piloted pre-study
and mapped to assess their relevance and specificity, and
refined working with a specialist librarian (see Add-
itional file 2: Table S2 - electronic search terms). We
searched four electronic databases: MEDLINE (1966–
Present), EMBASE (1947–Present), PsychINFO (1887–
Present), and CINAHL (1937–Present), and supple-
mented with referencing chain, grey literature electronic
survey, and expert recommendations. The last search
was run on 30 October 2018.
Quality appraisal
Study risk of bias was assessed using the validated Qual-
Syst review tool suitable for quantitative and qualitative
studies [35] by one reviewer (EY, IT, CJE), and a random
10% sample checked by a second author (CJE). Scores
that diverged by > 10% were discussed within the re-
search team. A single quality appraisal was undertaken
for studies reported in multiple publications (e.g. proto-
col paper and a main trial results paper). The QualSyst
assessment criteria include 14 items for quantitative
studies and 10 items for qualitative studies. Each item is
scored from 0 to 2 (0, not present; 1, partial; 2, yes; or
not applicable). The percentage of the total possible score
indicates the quality grade: < 50%, low; > 50 and < 70%,
medium; or > 70%, high. Study designs were categorised
using the Cochrane Effective Practice and Organisation of
Care (EPOC) grade system [36] (see Additional file 2:
Table S3).
Data screening, extraction, and analysis
Referencing software (Endnote version x8) [37] was used
to manage a database of search findings and remove
duplicates. Title and abstract screen by one reviewer
(EY/KS) and second independent review of 20% to test
the application of the eligibility criteria (CJE). Titles/ab-
stracts that met the review criteria, or if insufficient
information to determine eligibility, were subject to full-
text screening. Full-text articles were single-screened by
three reviewers (EY/KS/CJE). Full-text papers with un-
certain eligibility were reviewed by two reviewers and
eligibility agreed (EY/KS with CJE). A standardised data
extraction form was developed and piloted based on the
Cochrane Consumers and Communication Revie
Group’s data extraction template (see Additional file 2:
Table S4). Data included the study design and aim, the
population and context, method(s) of consent, recruit-
ment rate, and challenges and solutions. Study data were
extracted by one reviewer (CJE, EY, KS) and checked by
a second reviewer (CJE, EY, KS). We contacted two au-
thors to check availability of the publications in English.
Using narrative synthesis [33], textual descriptions from
extracted data for all studies were mapped to form
matrices for studies innovating research method, studies
using innovative methods, or considered ethics, legisla-
tion, or public attitudes. Each matrix was analysed and
coded in Microsoft Excel using thematic analysis to ex-
plore prominent themes. Higher quality studies were val-
ued with a greater strength in the final synthesis.
Transparent expert consultation
The TEC aimed to enhance the systematic review find-
ings by exploring the application of the findings in re-
search studies and areas little considered or uncertain in
the evidence. The TEC explored researchers’ and service
users’ perspectives on recruiting individuals with im-
paired capacity in research on EoLC. The TEC sought to
generate recommendations on processes of consent to
enable recruitment and explore the level of consensus.
Setting and participants
Participants were purposively sampled based on their ex-
pertise in conducting research involving adults with im-
paired capacity (including ethicists), caring for patients
with advanced disease, or a service user/carer (e.g. pallia-
tive care services), or a voluntary sector representative
(e.g. Alzheimer’s Society). Participants were invited to
the workshops held in the Cicely Saunders Institute,
King’s College London. Eligible participants included
members of the project’s expert panel (project appli-
cants), Project Advisory Group (invited experts in, for
example, ethics, and PPI and voluntary sector represen-
tatives) [see the “Acknowledgements” section], respon-
dents in the systematic review grey literature survey and
invited ethicists, clinicians, commissioners, researchers,
members of ethical committees, policymakers, and ser-
vice user and lay voluntary sector representatives.
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Identified professional participants received email invita-
tions for the workshop. Service user and lay voluntary
sector representatives were recruited via voluntary sector
groups including, for example, Alzheimer’s Society and
Independent Cancer Patients’ Voice. The respective
organisations circulated the invitation letter to their
members targeting those known to have an interest/ex-
perience of either a carer for an adult with impaired
capacity, being a patient with progressive illness, or sup-
porting research involving adults with impaired capacity.
The TEC used four stages:
Stage I: Identifying critical issues. The initial workshop
focused on critical issues identified from the systematic
review preliminary findings and expert opinion (e.g.
areas with limited empirical evidence and relevance in
the processes of consent for adults across the capacity
spectrum).
Stage II: Stakeholder workshop. Participants received a
pre-workshop briefing pack detailing the aim, critical is-
sues, and workshop format. The workshop comprised
presentations on the critical areas overviewing findings
from the systematic review followed by structured group
discussion involving 10–14 participants focusing on one
of the critical areas. Group discussions were digitally re-
corded. We used a structured nominal group process fa-
cilitated by a member of the research team. The
facilitator guided participants through a structured
process of (1) a brief discussion, (2) individual writing of
recommendations and ranking, and (3) participants in
turn stating their highest ranked recommendations until
individual lists were exhausted (or time exceeded) [31].
Scribes wrote the recommendations and ranking on a
flipchart, and each small group discussed and agreed on
the final priority order, then presented and discussed
with the whole group. Participants individually listed
and ranked recommendations from one to five (highest
to lowest) on structured A4 sheets detailing the respect-
ive group question, ranking scale and boxes to list rec-
ommendations, rank, and detail rationale.
Stage III: Delphi online consensus exercise. This is a
two-round online consensus exercise [32]. Recommen-
dations generated in the workshop were posted online to
the workshop participants, members of the expert panel
and Project Advisory Group, and respondents to the
grey literature survey. Participants received a persona-
lised email invitation and reminder after 2 weeks. The
online participants anonymously ranked, from one to
nine (strongly disagree to strongly agree), the extent they
agreed with a recommendation and used free-text spaces
to comment on each recommendation. Findings from
round 1 informed requirements to revise recommenda-
tions where comments suggested ambiguity. Round 2 re-
presented the revised recommendations and the median
score for each recommendation from round 1.
Participants again indicated their level of agreement
ranked from one to nine and provided free-text com-
mentary on, for example, rationale for ranking score.
Stage IV: Expert ‘think-tank’. The expert ‘think tank’
workshop aimed to aid data synthesis and inform the
solutions and recommendations in the statement by crit-
ically considering areas of contention/uncertainty identi-
fied in the consensus exercise and systematic review
findings. The think-tank aimed to understand the de-
bates surrounding these areas, the strengths and limita-
tions of the evidence, and the solutions for practice.
Participants were purposively selected from the work-
shop participants based on expertise, e.g. ethicists, lay
voluntary sector representative, researcher, and clinician.
Think-tank participations received a briefing report that
summarised for the respective area the systematic review
findings on the challenges and solutions identified in the
evidence base, and the recommendations and level of
agreement from the consensus exercise. The think-tank
used a format of presentations and debate, drawing on
structured nominal group process to facilitate partici-
pant agreement on the top two or three key solutions
for each area, and commentary on their thinking.
Participants discussed and debated these areas in groups
of 6–7. Discussions were digitally recorded, and scribes
recorded on flipchart the key debates.
Data analysis
Individual recommendations from the workshop and
their ranking were entered in Excel spreadsheets with
assigned participant identification numbers. Two re-
searchers (CJE, KS) coded and arranged recommenda-
tions by themes, duplicates were combined, and
recommendations arranged by priority ranking (1 high-
est to 5 lowest). Free-text comments were collated.
Digital recordings were reviewed to inform understand-
ing on the recommendations and debates presented,
with key points noted on the Excel spreadsheet for the
respective recommendation. The recommendations
retained participants’ original language where possible
with amendments guided by the expert panel to enhance
clarity and avoid repetition. The final recommendations
were those ranked the highest (≤ 3) and reviewed and
agreed by the expert panel and piloted (e.g. for clarity),
and then posted on the online consensus survey. Ana-
lysis of the consensus survey-scaled data used descriptive
statistics (frequencies and medians) and plots (box and
whisker plots) of interquartile ranges to analyse and in-
terpret levels of agreement. We used a conventional cat-
egorisation to interpret agreement (indicated, equivocal,
or not indicated) and strength of agreement (strict or
broad) used in previous consensus studies [28]. Table 1
details the categories by the respective median region
and IQR [38]. Narrative comments were collated by
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recommendation, and themes identified to understand
the issues raised and provide illustrative examples [32].
Results
Systematic review search results
The electronic database searches identified 5539 ab-
stracts after removal of duplicates with a further 179
publications identified from other sources (see Fig. 2).
Ninety-one publications met the eligibility criteria,
reporting 89 studies. Two studies included a protocol
and main results papers [39–42]. Studies were con-
ducted mainly in dementia (n = 23), palliative care (n =
16), and intensive care (n = 15) (Table 2). Publications
increased over time with the majority published after
2010 (n = 54). Studies were conducted mainly in the
USA (n = 35), UK (n = 29), or Canada (n = 9) (see Table 2
and Table 3, and Additional file 3: Table S8). The stud-
ies formed three main areas of (1) innovating research
methods to recruit adults across the capacity spectrum,
(2) applying consent processes across the capacity
spectrum in studies on serious illness, and (3) public at-
titudes on involving adults lacking capacity in research.
Quality appraisal
Overall, the quality of the included articles was medium
to high. Most quantitative (95.8%, n = 71) and qualitative
studies (88.9%, n = 17) were assessed as medium or high
quality (see Additional file 2: Table S5 quantitative stud-
ies and Table S6 qualitative studies). The proportion of
high-quality studies included was consistent across the
three main areas (56.8% ‘innovating research methods’,
56.6% ‘applying consent processes’, and 59.1% ‘public at-
titudes’). However, in the area of ‘public attitudes on in-
volving adults lacking capacity’, 9% were assessed as low
quality, compared with 0% in ‘innovating research
methods’ and 2% in ‘applying consent processes’. This
reflected in part the methodological nature of the studies
and poorer fit with the Qualsyst item criteria. The in-
cluded studies were mainly descriptive (n = 36) cate-
gorised as ‘non-experimental, longitudinal, cohort,
matched pairs, or cross-sectional, sound qualitative, or
analytical studies’, with few experimental (n = 20) or
quasi-experimental designs (n = 3) (see Additional file 3:
Table S7).
Innovating research methods to recruit adults across the
capacity spectrum
Thirty-seven studies were categorised as innovating re-
search methods (Table 3). Studies focused on participa-
tion in research involving individuals with cancer/
receiving palliative care (n = 6), dementia (n = 13), geriat-
ric care (all settings) (n = 2), delirium and mental health
services (n = 7), or intensive care (n = 5). While numer-
ous studies used standardised capacity assessment tools,
existing tools were often regarded as time-consuming,
and administration of a formal capacity assessment re-
duced recruitment, for example in an observational
study involving patients with delirium [99]. Formal cap-
acity assessment was considered of little value unless
aligned to the decisional requirements for study partici-
pation, notably the risks and the potential direct or
indirect benefits of participation. Overall, studies incor-
porated multiple components of the processes of con-
sent. These were tailored to individuals’ level of capacity
from mild to moderate impairment with a focus on en-
hancing informed consent, through to lacking capacity
requiring involvement of a consultee. For example, in
populations such as psychiatric or stroke patients, where
participants experienced varying levels of impaired cap-
acity, studies incorporated processes of enhanced in-
formed consent and consultee involvement [87, 90]. In
both studies, consultee advice was sought for a third of
participants (30.6% and 35.7%, respectively). The innova-
tions broadly mapped onto two sub-categories of ‘maxi-
mise individuals’ autonomy and decisional capacity in
the consent process’ and ‘processes of consent to enable
adults across the capacity spectrum to participate in
research’.
Maximise individuals’ autonomy and decisional capacity in
the consent process
Fifteen studies aimed to examine ways to enhance the
informed consent process to maximise decisional cap-
acity for adults with mild/moderate capacity or fluctuat-
ing capacity (see Table 3). Clinical trials required
applicable methods to facilitate understanding of com-
plex procedures, e.g. randomisation and clinical equi-
poise. For populations with mild/moderate dementia,
and other neuropsychological disorders such as
Parkinson’s disease, studies aimed to enhance various
facets of cognition. This involved in the informed con-
sent, for example, enhancing decisional capacity, under-
standing [90], reasoning, comprehension, and recall of
information. Across patient groups, key challenges to en-
abling participation in the informed consent process
were addressing concerns about causing distress for the
Table 1 Levels of consensus and agreement by median regions
and IQR [38]
Median regions and IQR Interpretation
7–9 Recommendation indicated
4–6 Recommendation equivocal
1–3 Recommendation not indicated
IQR in one region Strict agreement for recommendation
IQR in any three-point region Broad agreement for recommendation
IQR interquartile range
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person from receiving and considering study information
[43], and enabling understanding and recall of the infor-
mation provided [59, 103]. Moreover, in ensuring an in-
formed consent rather than participation based on trust
in the clinician and the study proposal considered a rec-
ommendation to take part [103]. A study observing con-
sent process for people with dementia (n = 46) and their
surrogate decision-maker (e.g. spouse) across six trials
(drug and non-drug) showed approaches to facilitating
the consent process and wide variation [60]. Importantly,
the consent process involved the person with dementia
and their surrogate, with the surrogate playing a major
role in facilitating the consent process. Use of a dual
consent was common, but assent from the person was
often implicitly implied not explicitly asked. The study
revealed wide variability in the conduct of the consent
process with higher risk drug trials generally more com-
prehensive in giving study information and assessing un-
derstanding compared to the non-drug trials. The
authors make recommendations on using a dual consent
Fig. 2 PRISMA flow diagram
Table 2 Population of interest categorised by the study focus
Patient population of
interest
Study focus on processes of consent
Innovating research methods (n = 37) Applying research methods
(n = 30)




Palliative care/cancer 6 [43–48] 8 [49–56] 2 [57, 58] 16
Dementia 13 [59–71] 10 [40, 42, 72–79] 1 [80] 24
Geriatric care 2 [81, 82] 3 [83–85] 0 5
Parkinson’s disease 1 [86] 0 0 1
Cerebral ischaemic stroke 2 [87, 88] 0 1 [89] 3
Mental health 6 [90–95] 2 [96, 97] 1 [98] 9
Delirium 2 [99, 100] 2 [101, 102] 0 4
Intensive care 5 [103–107] 5 [108–112] 4 [113–116] 14
General population 0 0 13 [117–129] 13
*89 studies are reported from 91 publications (includes two study protocols [40, 42] reported with the main study papers [39, 41]
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process and standardising the information provided to
encompass both study procedures and participants’
rights to, for example, withdrawal.
Successful enhanced informed consent processes often
included providing information in more than one format
(generally verbal and written) [61], improving under-
standing by using novel techniques (e.g. simplified story-
book, video) [91–93], and tailoring the process of study
approach to a person’s psychological and physical health
status [43]. In studies involving patients with schizophre-
nia [91, 93, 94] or dementia [62, 63], using a combin-
ation of multimedia techniques and flexibility to repeat
aspects of the study information significantly improved
individuals’ understanding about the study, and to give
an informed consent. Studies using enhanced informed
consent processes reported generally high consent rates
for eligible participants ranging from 68.0% (n = 53/78)
in an elderly patient population [81] (mean age 80.1
years) to 95.1% (n = 136/143) in patients with Parkin-
son’s disease (mean age 71 years) [86]. The addition of
social support from family members enhanced older in-
dividuals’ decision-making capacity. For example, a study
with hospitalised older cancer patients (MMSE mean
24.0, SD 4.1) achieved 74% (37/50) recruitment rate by
formal involvement of family members including pres-
ence during the consent process, asking their views, en-
couraging patients to discuss with the family members,
and taking their concerns into account [44]. In an RCT
(n = 136) on the effect of social support on the consent
process for patients with Parkinson’s disease (mean age
71 years, SD 8.6), the presence of a family member com-
pared to the patient alone showed effect on enhancing
comprehension and recall of the study information at
1 week (p = 0.012) and 1 month (p = 0.040) [86].
However, the evidence for using multiple or iterative
techniques to enhance individuals’ understanding and
reasoning was mixed. Variation was related to the con-
text and the processes used. Using techniques of itera-
tive learning by, for example, quizzing potential
participants’ understanding of the study and enhancing
how information was provided [86, 92] enabled study
engagement for individuals with lower levels of health
literacy from, for example, lower socioeconomic back-
grounds [82] or low- to middle-income countries
(LMICs) [94]. However, findings were mixed for studies
recruiting adults with dementia. RCTs showed enhanced
understanding (F [1, 29] = 7.17, p = 0.012) using a Power-
Point presentation, combined with verbal consent and
verbal re-explanation for participants with mild Alzhei-
mer’s disease (MMSE ≥ 19) (n = 53) [61], and using a
simplified memory and organisational aid to improve
understanding (χ2 = 8.2, df = 1, p = 0.004) (n = 110) [63].
Conversely, a RCT (n = 114) using multimedia and itera-
tive learning for participants with mild to moderate
Alzheimer’s disease (MMSE 20.9 (SD 3.9) and 22.5 (SD
3.4), by treatment arm) did not detect a significant effect
on decisional capacity (χ2(3) = 2.63, p = 0.453) [62].
Processes of consent to enable recruitment of adults across
the capacity spectrum
Twenty-one studies explored research methods in the
consent process for adults across the capacity spectrum.
Advance consent was advocated in two studies for par-
ticipants with the anticipated loss of capacity associated
with a progressive condition, e.g. dementia [45, 64]. Ad-
vance consent involved early informed consent when the
person had capacity, for example, on admission to a clin-
ical facility, with consent upheld at the point of loss of
capacity [64]. An area of contention was the requirement
(or not) in all research studies (Clinical Trial of an Inves-
tigational Medicinal Product (CTIMP) and non-CTIMP)
for the person to nominate a consultee for contempor-
aneous advice on continued participation in the study
[45]. Best practice was conducting the advance consent
process with the person and the consultee (e.g. a family
member), to discuss the person’s preference for contin-
ued participation should they lose capacity, and the role
of the consultee on contemporaneous advice aligned to
the person’s wishes and the context [45, 64]. This strat-
egy may minimise potential gatekeeping about continued
participation with disease progression [45]. Process con-
sent was proposed for studies with multiple time points
that involved individuals able to understand and appraise
information in the moment, but with difficulty retaining
and recalling study-related information in the future, for
example, individuals with mild/moderate dementia, pal-
liative care, and mental health populations [46, 65, 95].
Process consent involved continuous monitoring of the
validity of the informed consent provided at the begin-
ning of the study, for example, verbal confirmation of
consent at each time point with the formality of the
process consent proportionate to the risks involved in
participation.
Two studies reported the use of deferred consent in
circumstances of fluctuating capacity with participants
anticipated to regain capacity with reversibility of the
underlying cause, for example, an infection [100, 104].
Patients who were unlikely to recover or die were typic-
ally excluded. Patients entered the study without their
prior consent, with consent deferred until they regained
capacity and/or a consultee was approached. These types
of studies typically involved low-risk observational pro-
cedures conducted with, for example, older patients
with delirium [100] or in the ICU [104]. Using de-
ferred consent enabled the inclusion of participants at
the acute point of their illness spectrum. Deferred
consent appeared acceptable in the ICU study with an
80.1% (n = 214/267) consent rate [104], and sensitivity
Evans et al. BMC Medicine          (2020) 18:221 Page 30 of 55
analysis of the delirium study indicated that excluding
ALC would have compromised the detection of statis-
tically significant findings [100].
The main process of enabling adults lacking capacity
to participate in research was seeking advice from a con-
sultee about study participation. Most studies (n = 11)
explored the involvement of consultees across research
studies in geriatric/stroke care (all settings) (n = 7), ICU
(n = 2), or mental health services (n = 1) (Table 3). Stud-
ies conferred that the role of a consultee was not to pro-
vide substituted judgement, but rather to give advice
aligned with the patient’s wishes and well-being. This re-
quired researchers to consult patients as much as pos-
sible about participation and encourage them to identify
a consultee to advise on their behalf if they lost capacity
[66]. Key to this process was discussion and shared
decision-making between the consultee and the patient
when they had capacity [67], and including potential
consultees in early discussions with the person, while
capacitous about future participation in research [47].
An observational study in ICUs involving patients (n =
214) considered likely to regain capacity, and family
members (n = 445) as surrogate decision-makers, re-
ported that the only factor significantly associated with
patients’ confidence in their consultee’s consent decision
was having a previous conversation about research par-
ticipation [105]. Consultees also reported reduced stress
from their role when they could align their advice with
understanding of the person’s priorities [67]. However, a
study involving nursing home residents reported no as-
sociations with patients’ characteristics and consultee
decision to advise enrolment (54%, n = 90) (or not) [47].
While consultees were generally family members (in-
cluding close friends), consent processes also allowed
professional consultees or legal representatives to advise
on behalf of an individual lacking capacity. However,
guidance and regulation around the participation of
incapacitated adults in research and involvement of
consultees varied by jurisdiction. An international study
on stroke (n = 1005, across six European countries) [87]
reported that one in three patients lacked capacity to
consent. The study found considerable variation in the
jurisdictions’ respective enrolment requirements, detail-
ing four different processes for adults lacking capacity as
to who to approach as the proxy decision-maker (e.g. a
legal guardian, next of kin, or independent physician
consulting with the next of kin on the patient’s pre-
sumed will). In the USA, institutional review boards
(IRBs) were reported to differ in their rates of allowing
research involving incapacitated adults regardless of the
risks and benefits, and in who could act as a consultee
within the studies [117]. For instance, 15% of the IRBs
disallowed participation in research without direct bene-
fit regardless of risks, while 22% of IRBs accepted only
an authorised proxy, spouse, or parent as surrogates, ex-
cluding adult children and other family members. Stud-
ies conducted with patients with dementia [68, 69]
showed that requiring a legally appointed consultee led
to declining participation from family members due to
the bureaucracy and the time involved in the legal ap-
pointment. Such legal requirements could halt accumu-
lation of evidence required for enhancing care of
patients with impaired capacity.
Cluster consent was advocated for trials involving
adults with impaired capacity in palliative care [48] and
emergency medicine [106]. Cluster consent was under-
taken by a ‘cluster guardian’ giving written agreement
for treatment allocation of the defined cluster at the
level of a unit, e.g. a hospital ward. This enabled the allo-
cation of treatment at the cluster level. However, indi-
vidual consent from the person, or consultee advice, was
required for access to personal medical data for research
purposes. Recommendations in emergency medicine re-
search included enhancing recruitment using commu-
nity consent as a similar process with ‘group consent’ for
the study and individual ‘opt-out’ of the study at a later
stage, for example, once capacity was regained using a
similar process to deferred consent [106].
Applying consent processes across the capacity spectrum
in studies on serious illness
Thirty-two publications reported 30 original studies in-
volving adults with serious illness and impaired mental
capacity (n = 9046) (see Table 4). These studies were
conducted across clinical settings (e.g. hospices, hospi-
tals) and populations (e.g. elderly, dementia, delirium).
Fourteen (46.6%) studies were RCTs (including feasibil-
ity), and the remaining observational including prospect-
ive and cross-sectional designs. The studies enabled
analysis on the use of different consent processes and
the outcome of the recruitment rate for adults across
the capacity spectrum in clinical studies.
Most studies were conducted in palliative care (n = 8)
or dementia/geriatric care (n = 10). The studies used a
breadth of consent processes tailored to the respective
population. Methods included personal and/or profes-
sional consultee advice, advance and process consent,
enhanced informed consent, and deferred consent. Pro-
cesses showed variation in recruitment of eligible partici-
pants (range 23.9% [72] to 78.8% [42]). Use of a personal
consultee alone (e.g. a family member) was uncommon
and showed the greatest variability in the recruitment
rate. Four studies used personal consultee advice only
for adults lacking capacity [49, 50, 83, 108]. The recruit-
ment rates varied by study population and study design.
In a cross-sectional survey exploring patients’ palliative
care needs in hospital, the overall recruitment rate was
48.1% (654/1359) [49]. While most eligible patients
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lacking capacity had an identifiable personal consultee
able to advise, 8.1% of eligible patients (n = 109 /1359)
were not approached as no personal consultee was avail-
able. In contrast, in an RCT [83] on reducing pressure
ulcers, only 3.6% (n = 87/2445) of eligible patients who
lacked capacity were recruited compared to 82.3% (n =
1972/2395) of patients able to giveinformed consent.
The main reason for non-recruitment was no available
personal consultee (93.5%, 2286/2445), and when avail-
able, 45.3% declined to give advice (n = 72/159).
Three studies used both a personal and a professional
consultee to provide advice with an initial approach to a
personal consultee, and if unavailable an approach to a
professional consultee [51–53]. Abernethy and colleagues
[51] achieved a high recruitment rate (n = 461, 75.9%)
using this joint approach in a low-risk non-invasive cluster
RCT on palliative care in community settings. A MMSE
score of ≤ 24 indicated the need for consultee advice. Only
seven patients were ineligible due to consultee unavailabil-
ity. The recruitment process used a resource-intensive de-
fined recruitment plan that sought to facilitate
recruitment by minimising patient and clinician burden.
Similarly, a feasibility cluster RCT of clinically assisted hy-
dration in cancer patients in the last days of life used mul-
tiple processes of informed consent for patients with
capacity (n = 16, 8%), and advice from a personal (n = 161,
80.5%) or professional consultee (n = 23, 11.5%) for adults
lacking capacity, and process consent throughout the
study [53]. The multiple consent processes enabled a
91.3% recruitment rate (n = 200/219) of eligible patients
from four cancer centres and eight hospices. Only 5.9%
(n = 13/219) of the eligible participants declined to partici-
pate, and none withdrew. Using clinical observations for
data collection minimised burden for patients and family
members. However, a competitive recruitment strategy
caused variation in recruitment rate between clusters and
imbalance in the trial arms (n = 73 treatment arm and n =
127 control arm). Conversely, an RCT of antibody re-
sponse to influenza vaccination for older people in care
homes incorporated multiple processes of consent [52].
But care home staff were hesitant to act as a professional
consultee in the absence of a personal consultee. A total
of 304 (54.5%) eligible individuals were excluded for this
reason, and recruitment of only 8.9% of eligible residents
who required a professional consultee (n = 40/448). How-
ever, the study acceptable was mixed with 75.2% of per-
sonal consultee advising enrolment (n = 82/109), but only
37.7% of residents with capacity consented to recruitment
(n = 155/411). Greater clarity on the responsibility of the
professional consultee was required to enable care staff to
act in this role, particularly in a trial involving invasive
procedures.
Seeking advice from a consultee on enrolment was
prominent in studies involving patients with dementia or
delirium. Depending on the context of the study, recruit-
ment rates ranged from 23.9% [72] to 78.8% [42]. Most
studies in dementia took place in nursing homes/resi-
dential care homes [40, 42, 72–75], with only two RCTs
conducted in hospital both on delirium [101, 102]. Com-
mon challenges to participation were relatives advising
against patient enrolment [40, 73, 101], unavailability of
a personal consultee [74, 76, 101], and care home staff
acting as professional consultees declining to give advice
for 44.9% of the eligible participants [77]. To overcome
potential hesitancy from consultees required active en-
gagement with consultees, keeping in touch and being
flexible, highlighting potential benefits, and lowering
burden for the consultee [75]. To minimise exclusion of
eligible patients due to unavailability of personal consul-
tees, studies used processes of a professional consultees
and a clear recruitment strategy detailing the procedures
[42, 78]. A cohort study involving people with dementia
from six care homes achieved 62.1% patient recruitment
rate (n = 133/215) using a process of informed consent
when possible (n = 65/89, 73.8%) and personal consultees
(n = 68/126, 54%) [74]. The study reported the import-
ance of engaging with patients and families by using a
short summary sheet to enable understanding and par-
ticipation. However, 49 eligible patients had no available
personal consultee and were excluded [74].
Two studies [54, 84] in palliative care employed advance
consent, followed by process consent (or personal con-
sultee) processes. In a feasibility RCT of two medications
for the treatment of death rattle, 54.2% (58/107) of eligible
patients with capacity provided advance consent. However,
due to the complexities of the patient population and un-
certain prognosis, only 25.9% (15/58) of patients were ran-
domised [54]. The consent process was resource intensive
to recruit the target sample size and emotionally draining
for patients as it required conversations about an event
which may not occur. Most patients accepted the advance
consent process, with only 16 of 58 declining. A prospective
cohort study examining health trajectories and outcomes in
patients over 85 years old in usual place of residence
achieved a 72.0% (1042/1453) recruitment rate [84]. Indi-
viduals who provided advance consent were also asked to
nominate a personal consultee. Throughout the study, cap-
acity of the recruited participants was assessed, and the
nominated personal consultee was contacted if needed.
Only five consultees declined, and nine were unavailable.
The recruitment process was facilitated in multiple ways in-
cluding using different consent and capacity assessment
protocols for respective settings, tailoring the study infor-
mation to the target population, flexibility towards those
with fluctuating capacity, identifying personal consultees,
training researchers, sensitively handling complex situa-
tions, and allocating time and resource to engage and keep
in touch with family and care home staff.
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Four studies that took place in ICUs used informed
consent and consultee advice, and deferred consent pro-
cesses [109–112]. Pilot RCTs of complex interventions
(non-invasive) used deferred consent processes [109,
110]. Patients agreed verbally to study enrolment, and
their personal consultees gave written advice. Once pa-
tients recovered, they were approached for an informed
consent [109]. The study achieved 71.5% recruitment
rate. However, the possibility of coercion was raised with
some patients indicating they felt unable to decline ver-
bal enrolment, and consent bias with the exclusion of
patients with no personal consultee. In another pilot
RCT, the next of kin of 83.6% of patients who lacked
capacity in the moment of data collection provided de-
ferred advice at the point of discharge. Although this
study had a 71.5% recruitment rate, 16.3% declined to
participate. A further RCT involving both adults with
capacity to provide informed consent and personal
consultee advice for incapacitated patients showed only
8/510 eligible individuals declined participation [112].
Similarly, an RCT involving a blood test for patients
with severe dyspnoea used deferred consent [85] and
showed high acceptability with only 3.8% (28/747) with-
drawing consent once regained capacity or on consultee
advice. Only 0.9% (7/747) were excluded as unable to
obtain deferred consent or consultee advice. An ethno-
graphic observational study in ICU used informed
consent and personal or professional consultee advice
successfully to recruit 16 patients and 19 relatives with
a clear consent protocol aligned to minimal risk of
participation [111].
Enhanced consent processes were limited to studies
involving adults with intellectual disabilities [96, 97] and
in palliative care [55]. A study investigating falls in
people with intellectual disability aimed to maximise an
individual’s ability to provide informed consent for
themselves achieved a recruitment rate of 58.8% (n = 40/
68). The study enhanced consent processes by involving
family members and healthcare professionals in the
process, using a questionnaire to assess capacity, and
conducting multiple observations [97]. A personal con-
sultee was sought for adults lacking capacity. However,
over 40% of relatives advised non-participation in the
study on behalf of the person as they considered the
consent process too time-consuming and burdensome.
A cross-sectional study on use of antipsychotic medica-
tion for people with intellectual disabilities recruited 159
eligible participants using informed consent and
professional consultee comprising legal representative
[96]. However, no denominator was stated. Finally, a
pilot study of patients admitted to a hospice exploring
levels of cognitive impairment sought to minimise the
burden of informed by allowing written or oral informed
consent [55].
Public attitudes on enrolling adults lacking capacity in
research
Studies (n = 22) on attitudes towards enrolling adults lack-
ing capacity in research consistently reported the accept-
ability of involving consultees to enable recruitment.
However, the level of acceptability varied associated with
the nature and purpose of the study (see Additional file 3:
Table S8 reporting the studies’ key findings, and suppl. 9 –
additional reporting [130–133]). Most studies (59.1%) were
conducted with public members (including researchers,
healthy populations, IRBs) and used observational designs
(e.g. survey) to explore attitudes about research with critic-
ally ill patients (e.g. conducted in intensive or emergency
care settings), or focused on Alzheimer’s disease, stroke,
cancer, intellectual disabilities, overall incapacitated indi-
viduals, or proxy decision-making for study enrolment.
Overall, stakeholders considered it acceptable to use substi-
tute decision-making to enrol adults lacking capacity in re-
search, especially for low-risk studies. Acceptability focused
on prioritising a person’s wishes and the potential benefits
for the person, rather than the burden of acting as a proxy
decision-maker.
Transparent expert consultation
The systematic review findings identified three critical
areas debated in the TEC including:
1) Time and design of the consent process: ‘How can
we enhance the timeliness of the consent processes
for adults with fluctuating or deteriorating capacity
in research on palliative and EoLC?’
2) Enhancing consultee and supportive decision-
making: ‘How can we enhance proxy decision-
makers’ role in the process of consent for adults
who lack capacity?’
3) Ethics, resources, and expertise: ‘What are the key
considerations in planning the consent process in
studies involving adults lacking capacity and
communicating this to a research ethics
committee?’
The TEC stakeholder workshop involved 39 partici-
pants of the 83 invitees (47.0%). The participants repre-
sented service users/lay voluntary sector representatives
(n = 13, 33.3%), researchers (n = 15, 38.5% including ethi-
cists), clinical academics (n = 9, 23.1%), and clinicians
(n = 2 5.1%). Voluntary sector representatives included
lay members who were carers and/or patients living with
a progressive condition recruited from charities for
people with dementia (Age UK and Alzheimer’s Society)
and cancer/palliative care (Brainstrust, Marie Curie,
Independent Cancer Patients’ Voice, National Cancer
Research Institute, and the then National Council for
Palliative Care). The group generated 184
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recommendations on the three areas (area 1, n = 60 rec-
ommendations; area 2, n = 72 recommendations; and
area 3, n = 53 recommendations). Following data ana-
lysis, 29 recommendations were presented in the online
Delphi Survey round 1 (see Additional file 4: Table S10 -
Delphi participant characteristics). The recommenda-
tions pertained to timeliness and design of the consent
process (area 1, n = 7 recommendations), enhancing con-
sultee and supportive decision-making (area 2, n = 10
recommendations), and ethics resources and expertise
(area 3, n = 12 recommendations) (see Additional file 4:
Table S11 – Delphi round 1 recommendations and Fig.
S12 – round 1 box and whisker plots). The Delphi sur-
vey round 1 involved the workshop participants (n = 39)
and individuals unable to attend the workshop (n = 4).
51.8% participated (n = 43). Round 2 involved the round
1 respondents only (83.7% response rate, n = 36). Find-
ings from round 1 analysing 454 free-text comments in-
formed revisions to 11 recommendations to reduce
ambiguity. This mainly concerned the use of the term
‘consultee’ in relation to legislation. In round 2, consen-
sus was apparent for 24 recommendations with strict/
broad agreement and five considered equivocal (see
Additional file 4: Table S13 - Delphi round 2 recommen-
dations and Fig. S14 – round 2 box and whisker plots).
No recommendations were not indicated. The top rec-
ommendations by respective areas were as follows:
 Area 1. ‘Information about a research study is
comprehensible, short and written in accessible
language’ (R2, median 9, IQR 9–9) and ‘Although
the legal significance of advance consent will vary
depending on the relevant legal framework, it is
good practice for researchers to seek an advance
consent while individuals have capacity to consent
for themselves, for example, shortly after a diagnosis
of a progressive illness’ (R10, median 8, IQR 7–9)
 Area 2. ‘The consent process is tailored to the
individual’s needs, capabilities and values with
researchers observing for non-verbal and verbal cues
that may indicate an individual may wish to with-
draw’ (R9, median 9, IQR9–9) and ‘Advance care
planning to include discussing and recording in a
Statement of Wishes document an individual’s nom-
inated or personal consultee whose opinion on par-
ticipating in a research study is sought if the patient
loses capacity’ (R21, median 8, IQR 7–8)
 Area 3. ‘Researchers to demonstrate to Research Ethics
Committees a clear process of consent for potential
participants with compromised capacity that details
how the researchers will proceed to tailor the consent
process to maximise individuals’ ability to consent for
themselves and when and how they will seek an
opinion from a consultee’ (R29, median 9, IQR9–9)
and ‘Health and social care practitioners to recognise
research as a core clinical activity in a similar way as
teaching and training’ (R23, median 9, IQR 9–9)
Three main areas were considered equivocal and were
debated in the expert ‘think-tank’, and solutions pro-
posed by consensus (see Additional file 4: Box S15 –
main areas and top solutions). Nineteen experts attended
the think-tank, representing researchers/clinical aca-
demics (n = 12), clinicians (n = 2), lay voluntary sector
representatives (n = 3), and PPI member (n = 1). The
three equivocal areas comprised the following:
 Area 1. Involving and supporting consultees in the
decision-making process with uncertainty on how best
to support consultees to engage in the research process,
with four recommendations indicating equivocal broad
agreements (recommendations 6, 8, 15, 22, 27)
 Area 2. Practitioner training and education with
agreement on the requirement to increase training and
support to researchers and clinicians, but areas of
uncertainty concerned for example how to provide and
disseminate training and guidance, and how to fund (R5)
 Area 3. Legislative frameworks and the
incorporation into research practice
A prominent equivocal area surrounded the Mental Cap-
acity Act 2005 [29] legislation in England and Wales. The
key solutions proposed concerned amendments in the sup-
porting guidance for the Act to enable greater flexibility in
the role of the ‘professional’ consultee in, for example, how
they are identified. The Expert Panel concurred that the
MCA process of review of an advance consent being upheld
(or not) by a consultee if a participant lost capacity to con-
sent should be applied to all clinical trials and not limited
to trials of non-pharmacological interventions. This would
include for example pharmaceutical trials where advance
consent is upheld without requirement for consultee review
if a person loses capacity in European legislation [134].
Discussion
This synthesis of evidence from systematic review and
TEC identified challenges and solutions to including indi-
viduals across the capacity spectrum in research on EoLC.
Our findings produce the MORECare_Capacity statement
detailing 20 best practice solutions and implementation
requirements to maximise study participation across the
capacity spectrum (Table 5 and Fig. 3). The statement
provides much needed guidance to maximise opportun-
ities for adults across the capacity spectrum to participate
in research. It is relevant for researchers, members of re-
search ethical committees, individuals overseeing research
governance, clinicians, the public, service users, and vol-
untary sector representatives. The statement details
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solutions for study designs at the participant level to maxi-
mise individual autonomy, enhance the contribution of
proxy decision-makers, and ensure time and resources to
enable participation and recruitment strategies that antici-
pate and plan for varying and changeable levels of cap-
acity. At the structural level, key activities are engaging
research ethical committees in how to include adults lack-
ing capacity in research by auditing ethical approvals to
review decision-making and inform research practice, and
promoting the importance of research in health and social
care to improve clinical care and raise awareness on
recruiting adults from across the capacity spectrum to
Table 5 MORECare_Capacity statement solutions on recruiting adults with impaired mental capacity at the end of life in research
Solutions
Ethics 1. Researchers should design all aspects of the study in the context of potential risk, burden, and benefit of
study participation.
2. Institutional review boards and research ethical committees should have transparent decision-making pro-
cesses to ensure consistency on ethical approvals for studies from various health specialties involving adults
across the mental capacity trajectory.
3. The individuals (e.g. relative, friend, formal carer, nursing home staff, healthcare staff) who can act as a
consultee to advise on whether the individual would have wanted to participate in the research study had
they had capacity should depend on the nature of the study, rather than legal restrictions.
4. Researchers should be able to demonstrate a clear process of consent for potential participants with
compromised capacity that details how the researchers will tailor the consent process to maximise an
individual’s ability to consent for themselves and when and how they will seek an opinion from a consultee.
Maximising individual autonomy 5. Clinicians should engage in research participation conversations with patients at the early stages of illness,
discussing varying levels of risk, burden, and benefit, and document the person’s preferences and wishes in for
example an advance directive.
6. Individuals who are likely to lose capacity should be asked to designate a consultee whose opinion on
their participation in a research study will be sought if the individual loses capacity.
7. For individuals who have capacity to consent in the moment, but overtime may not remember the
discussion, process consent should be adopted whereby researchers re-confirm the individual’s wish to partici-
pate at each data collection time point.
8. Researchers should check for non-verbal (e.g. agitation) and verbal cues (e.g. ‘I’m unsure why you are ask-
ing me’) that may indicate a wish to withdraw during the study.
Involving consultees 9. Personal consultees should be present in research participation conversations with patients at the early
stages of illness.
10. Where possible, to improve social support, personal consultees/family members should be engaged in
the (enhanced) informed consent process for adults with impaired capacity.
11. The nature and extent of the responsibility of a consultee acting on behalf of a patient should be
clarified.
12. Establish a national body to provide support and information to family members/informal carers acting as
personal consultees.
Tailoring recruitment process to
need
13. Researchers should incorporate in the study design research participation information and (where
applicable) data collection tools in multiple formats (e.g. verbal, written, electronic).
14. Studies where potential participants are expected to be adults across the mental capacity trajectory
should incorporate multiple consent processes (e.g. personal and professional consultees, informed and
process consent).
Time 15. When possible, potential participants should be allowed time for further discussions regarding their
research participation decision.
16. The study design should allow time proportionate to the risk, burden, and benefit of participation for
consent or consultee decision (before or after research participation if consent is deferred).
17. Researchers should build in the time required to engage with and train clinical staff who will be involved,
and those who might act as professional consultees in the study.
Enhancing the research culture and
infrastructure
18. Health and social care practitioners should recognise research as a core clinical activity in a similar way as
teaching and training.
19. Clinicians should be supported and provided with training to ensure they are confident in their skills to
discuss research studies with patients (and/or family members) during routine clinical contact.
20. Health and social care practitioners should support adults across the mental capacity trajectory at all
stages of the research study by considering the person’s best interests and individual wishes and preferences
to uphold individual autonomy and minimise the risk of harm, and enable family members to act as a
personal consultee by ensuring sufficient information and understanding about the role.
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enhance the applicability of research findings for service
users. The statement is intended as a framework for ‘best’
research practice. A statement cannot always anticipate
change in an individual’s circumstances or wishes. On-
going review is always required by the consultee and re-
searchers of an individual’s best interests.
Our findings demonstrate that despite ethical chal-
lenges and legislative requirements, recruiting adults
with impaired capacity in research is possible with care-
ful consideration of the context, study design, and the
resources required to enable participation. The main so-
lutions for maximising research with incapacitated adults
centred around early involvement of the person while
they had capacity to indicate their preferences for re-
search participation, and nomination and engagement
with consultee(s) in these discussions. It is important to
recognise that acting as either a personal (e.g. family
member) or nominated (e.g. clinician) consultee can be
burdensome, with burden increasing in studies which
carry risks or little benefit the patient directly. A priority
for consultees is to have sufficient time and information
about their role and to have an awareness of the person’s
wishes through earlier discussions and documenting a
person’s wishes about research participation in, for ex-
ample, an advance directive [21] or study specific in an
advance consent. Figure 3 summarises the different pro-
cesses across the capacity spectrum and sets out key
factors to anticipate and plan for in a research study. In-
corporation of our solutions in research studies on EoLC
could increase the potential to recruit a representative
sample of those intending to benefit from palliative care
services and treatments. Involving patient groups with
impaired capacity would increase generalisability of re-
search findings by not limiting the evidence base to
those with capacity and less advanced disease, and sus-
tainability of the tested interventions in clinical care.
Our solutions are informed by methodological and ori-
ginal research studies, and expert consensus. Import-
antly, surveys of the public and stakeholders consistently
endorse the involvement of adults with impaired cap-
acity in research and specifically in palliative care [135].
Ethically, research studies must endeavour to ask ques-
tions important for care and treatment, be designed to
enable participation and minimise potential for harm,
and demonstrate to research ethical committees a clear
rationale for the study design and processes of consent
for adults across the capacity spectrum (R29). In turn,
ethical research committees must ensure transparency
and consistency on ethical approvals for adults lacking
capacity (R28). Working in this way seeks to uphold in-
dividual rights of, for example, autonomy to participate
(or not), beneficence, and justice [136]. Beneficence in
research on EoLC is important. Individuals with ad-
vanced disease are unlikely to benefit from the research
Fig. 3 How ‘best’ to include adults nearing the end of life in research
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findings seeking to improve care and treatment, but par-
ticipation can enable a sense of contribution to society,
of their ‘voice’ being valued and foster a sense of altru-
ism [137]. Excluding individuals because of perceptions
of vulnerability associated with advanced disease and im-
paired capacity may be considered unjust [3]. It denies
equal opportunity for individuals living with progressive
conditions to contribute to care and treatment in pallia-
tive care across the illness spectrum. To facilitate partici-
pation in research, our findings identify two key areas:
‘enabling and empowering consultees’ and ‘a carefully
constructed and resourced recruitment strategy’.
Enabling and empowering consultees
While techniques for enhancing autonomy are imperative
to maximise individual decision-making, for adults with
impaired capacity in EoLC studies, proxy decision-makers
were crucial to enable recruitment. Consultees as proxy
decision-makers sought to represent patients’ wishes and
best interests [105]. Their role was vital in enabling par-
ticipation in research for adults across the capacity
spectrum. While an array of consent processes can be im-
plemented depending on the condition and level of cap-
acity of the individual, successful participation of
individuals relied on empowering and educating all those
involved (patients, families, health and care staff, re-
searchers, ethical committee members). Introducing pa-
tients to research studies while they were competent, and
their family members, empowered patients and their fam-
ilies. Careful consideration is required to identity the right
proxy decision-maker. Consultees sought to consider the
benefits, risks, and burden to the person, and align their
advice with understanding of the person’s wishes. Earlier
conversations enabled family members to align advice on
participation with understanding on the person’s wishes,
particularly in comparatively high-risk studies [47, 67].
Similarly, West et al. in their systematic review on ethical
challenges in dementia research reported differences in
consultees advising enrolment with a higher proportion
willing to provide consent for non-invasive studies com-
pared to invasive studies, even with no potential direct
benefit for the patient [21]. Our findings show that the
presence of family members during enhanced consent
processes enabled study participation by increasing oppor-
tunity and support for the person to discuss their prior-
ities [44, 86]. Although personal consultees were crucial,
studies reported higher recruitment rates when they used
a nominated/ professional consultee to advise if no per-
sonal consultee was available (compared to designs with a
personal consultee alone). In contexts where being a pro-
fessional consultee was unfamiliar, support and training
for professional consultees were required to increase con-
fidence and understanding of their role, for example, in a
care home with little/no embedded research culture.
A carefully constructed and resourced recruitment
strategy
Recruitment strategies in research on EoLC must align with
the target population and anticipate and plan for varied and
changeable levels of capacity associated with progressive
disease. Even with strict eligibility criteria, potential partici-
pants within one study will likely present with varying and
changeable levels of capacity. Our findings identify the ne-
cessity to have multiple consent processes in place aligned
to the target population, context, and study aim to recruit
individuals across the capacity spectrum [51, 53]. Studies
on EoLC demonstrate the feasibility of using multiple pro-
cesses in, for example, trials in the dying phase [54] and ob-
servational cohort studies [40, 77]. The studies demonstrate
the resource intensity and careful planning required to im-
plement complex processes of advance consent when the
person had capacity, and if/when capacity is lost, the in-
volvement of proxy decision-makers (e.g. family or profes-
sional). Boland et al. echo these findings in their systematic
review on recruitment strategies in trials involving people
with serious illness [26]. Our findings show that where pos-
sible, researchers sought to maximise individual’s auton-
omy, through consent processes such as enhanced,
advanced, deferred, and process consent, and when lacked
capacity incorporating a personal and/or professional con-
sultee declaration that sought to align with understanding
of the person’s wishes and preferences. Enhanced consent
was feasible and acceptable to augment understanding and
reasoning by using methods of multiple formats and involv-
ing family members [61]. Similarly, Hostiuc et al. reported
from their meta-regression that using multimedia to
present study information significantly improved under-
standing, reasoning, and appreciation and enabled informed
consent for adults with schizophrenia in clinical trials [22].
There is clearly opportunity to incorporate advances from
other specialities, but with consideration if a successful
strategy in one population is transferable to another. Differ-
ent conditions impair different components of cognition,
with variance in transience and progression (e.g. between
schizophrenia and dementia), and prospect of recovery or
not (e.g. between emergency medicine and palliative care).
Further process evaluation of multimedia techniques is
needed to determine the content and duration as the active
ingredients of the techniques which leads to enhanced deci-
sional capacity in studies for specific populations. Toolkits
are useful resources to inform consent processes that
encompass the heterogeneity of for example palliative care
populations and the legislative framework for the
respective jurisdiction and context [138] (See page 96
in for example [139]).
Limitations
Our incorporation of systematic review and expert consult-
ation and consensus enabled consideration of a breadth of
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evidence and the application in study designs to enable par-
ticipation across the capacity spectrum. The search strategy
enabled consideration of a breadth of research methods
employed in different clinical populations and contexts re-
quired to underpin the MORECare_Capacity statement.
But the breadth of our strategy may have limited the identi-
fication of all relevant original research studies involving
adults with serious illness and impaired capacity. While we
present evidence from an array of original research studies
including qualitative work, future work is required to sys-
tematically review recruitment processes for clinical trials
in palliative care. The use of search terms to identify eligible
studies was limited by poor reporting of recruitment pro-
cesses and details regarding mental capacity of eligible par-
ticipants [55]. To address this, we used supplementary
processes of reference chaining and seeking recommenda-
tions from experts of key studies. In line with international
reporting guidelines [28, 140], researchers should provide
detailed information about recruitment processes and dif-
ferentiate between participants who consented for them-
selves and those requiring a proxy decision-maker. This
would improve assessment of the success of the recruit-
ment methods used to inform research practice [55]. While
recommended research methods can be generalisable, these
need to be tailored to the respective setting, context, and
culture. Our findings were limited to predominantly West-
ern contexts. This reflects the concentration of palliative
care research in, for example, the USA and Europe [141].
Finally, the study included lay representatives in the work-
shops and Delphi Survey, but PPI in the data synthesis and
voluntary sector representation was limited to membership
of the Project Advisory Group. Greater exploration is re-
quired in areas directly impacting on patients and families,
for example, the use of advance directives to record a per-
son’s preferences for research participation (R21), and es-
tablishing a national body to provide support and
information to family members acting as consultees (state-
ment solution 12).
Conclusions
To meet the increasing need for palliative care requires
greater provision of evidence-based services and treatments,
which is informed by research that includes adults from
across the capacity spectrum. Our findings show that con-
ducting research involving adults with impaired capacity is
feasible and acceptable, and it is ethically unjust to exclude
them. Inclusion requires careful planning of processes of
recruitment that are aligned to varying and changeable
levels of capacity, and the nature and intent of the research
study to minimise risk of harm. Studies must ask research
questions important for patients and families in the
provision of services, care, and treatment in serious health-
related illness. This review and TEC present innovative re-
search methods, solutions on enhancing use, and critical
consideration on implementation in research studies in dif-
ferent populations, clinical settings, and research designs.
The MORECare_Capacity statement provides solutions
underpinned by carefully considered evidence on involving
and supporting consultees, consent processes across the
capacity spectrum, and decision-making with adaptations
for the respective care setting. The solutions have applic-
ability for vulnerable patient populations in palliative care
and beyond such as mental health and emergency medi-
cine. The application of the solutions stated requires con-
sideration within respective jurisdiction’s legislative
framework. Future research is required on the applicability
of the MORECare_C statement for non-Western cultures
and low- to middle-income countries.
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Mental State Examination; NoK: Next of kin; Non-CTIMP: Clinical Trial of an
Investigational Non-medicinal Product; PRISMA: Preferred Reporting Items for
Systematic Reviews and Meta-Analyses; QoIC: Quality of informed consent;
RCT: Randomised controlled trial; SD: Standard deviation; TEC: Transparent
expert consultation
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